Blood freezing to nearly absolute zero temperature: -272.29 degrees C.
Cravalho EG, Huggins CE, Diller KR, Watson WW.Cravalho EG, et al.
. Yearb Med Inform. 2004.PMID: 27706321No abstract available.
.
.
.
Item in Clipboard
Item in Clipboard
.
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
Marconi VC, Ramanan AV, de Bono S, Kartman CE, Krishnan V, Liao R, Piruzeli MLB, Goldman JD, Alatorre-Alexander J, de Cassia Pellegrini R, Estrada V, Som M, Cardoso A, Chakladar S, Crowe B, Reis P, Zhang X, Adams DH, Ely EW; COV-BARRIER Study Group.
. J Am Acad Dermatol. 2020 Oct 24:S0190-9622(20)32860-7. doi: 10.1016/j.jaad.2020.10.048. Online ahead of print.J Am Acad Dermatol. 2020.PMID: 34526230No abstract available.